Lynn Cleary

730 total citations
15 papers, 506 citations indexed

About

Lynn Cleary is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Pharmacology. According to data from OpenAlex, Lynn Cleary has authored 15 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in General Health Professions and 4 papers in Pharmacology. Recurrent topics in Lynn Cleary's work include Innovations in Medical Education (6 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmaceutical Economics and Policy (3 papers). Lynn Cleary is often cited by papers focused on Innovations in Medical Education (6 papers), Pharmaceutical industry and healthcare (3 papers) and Pharmaceutical Economics and Policy (3 papers). Lynn Cleary collaborates with scholars based in United States, United Kingdom and Canada. Lynn Cleary's co-authors include Matthew L. Mintz, Rebecca M. Minter, Carol A. Aschenbrener, Frederick Sierles, Carol Carraccio, Maureen J. Garrity, Steven Lieberman, Brenessa Lindeman, Jason Chao and Mark C. Wilson and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Lynn Cleary

15 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Cleary United States 8 336 163 153 136 105 15 506
Anne Simmenroth-Nayda Germany 12 214 0.6× 63 0.4× 137 0.9× 152 1.1× 108 1.0× 24 466
Amy C. Brodkey United States 11 220 0.7× 201 1.2× 150 1.0× 188 1.4× 23 0.2× 14 397
Lynne Allery United Kingdom 12 237 0.7× 29 0.2× 171 1.1× 48 0.4× 44 0.4× 26 383
Ana H. Traylor United States 5 121 0.4× 12 0.1× 200 1.3× 67 0.5× 40 0.4× 8 431
Alessandra Lo Scalzo Italy 5 204 0.6× 26 0.2× 289 1.9× 136 1.0× 47 0.4× 11 495
Virginia A. Sharpe United States 13 130 0.4× 23 0.1× 197 1.3× 56 0.4× 17 0.2× 29 457
Kei Mukohara Japan 9 107 0.3× 56 0.3× 287 1.9× 153 1.1× 17 0.2× 19 420
Anne G. Pereira United States 16 287 0.9× 4 0.0× 267 1.7× 99 0.7× 87 0.8× 32 537
Matthew K. Wynia United States 7 113 0.3× 19 0.1× 292 1.9× 95 0.7× 16 0.2× 18 454
Marsha Rosenthal United States 6 64 0.2× 16 0.1× 226 1.5× 108 0.8× 14 0.1× 9 391

Countries citing papers authored by Lynn Cleary

Since Specialization
Citations

This map shows the geographic impact of Lynn Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Cleary more than expected).

Fields of papers citing papers by Lynn Cleary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Cleary. The network helps show where Lynn Cleary may publish in the future.

Co-authorship network of co-authors of Lynn Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Cleary. A scholar is included among the top collaborators of Lynn Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Cleary. Lynn Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Darko, William, Robert W. Seabury, Christopher D. Miller, et al.. (2021). Implementation of a formal pharmacy residency research certificate program. American Journal of Health-System Pharmacy. 78(5). 436–446. 8 indexed citations
3.
Cleary, Lynn, et al.. (2020). Amiodarone-Associated Neurotoxicity. American Journal of Therapeutics. 28(1). e165–e166. 4 indexed citations
4.
Byyny, Richard L., Lynn Cleary, Dagoberto Estévez-Ordoñez, et al.. (2019). Alpha Omega Alpha Honor Medical Society: A Commitment to Inclusion, Diversity, Equity, and Service in the Profession of Medicine. Academic Medicine. 95(5). 670–673. 6 indexed citations
5.
Englander, Robert, Timothy C. Flynn, Stephanie Call, et al.. (2016). Toward Defining the Foundation of the MD Degree: Core Entrustable Professional Activities for Entering Residency. Academic Medicine. 91(10). 1352–1358. 244 indexed citations
6.
Sierles, Frederick, Matthew L. Mintz, Stephanie R. Starr, et al.. (2015). Changes in Medical Students’ Exposure to and Attitudes About Drug Company Interactions From 2003 to 2012. Academic Medicine. 90(8). 1137–1146. 18 indexed citations
7.
Trief, Paula M., et al.. (2011). A Case-Based Approach to Chair Development. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Sierles, Frederick, Amy C. Brodkey, Lynn Cleary, et al.. (2005). Medical Students’ Exposure to and Attitudes About Drug Company Interactions. JAMA. 294(9). 1034–1034. 139 indexed citations
9.
Ogden, Paul E., Michael J. Battistone, Lynn Cleary, et al.. (2005). Do Attending Physicians, Nurses, Residents, and Medical Students Agree on What Constitutes Medical Student Abuse?. Academic Medicine. 80(Supplement). S80–S83. 41 indexed citations
10.
Sierles, Frederick, Amy C. Brodkey, Lynn Cleary, et al.. (2005). Medical Students' Exposure to and Attitudes About Drug Company Interactions. 14 indexed citations
11.
Cleary, Lynn. (2003). Population-based preventionA core competency in medical education. American Journal of Preventive Medicine. 24(4). 161–163. 5 indexed citations
12.
Cleary, Lynn, Linda Lesky, Henry J. Schultz, & Lawrence Smith. (2001). Geriatrics in internal medicine clerkships and residencies: current status and opportunities. The American Journal of Medicine. 111(9). 738–741. 14 indexed citations
13.
Gruppen, Larry D., Cyril M. Grum, R M Fincher, et al.. (1996). Multi-site reliability and validity of a diagnostic pattern-recognition knowledge-assessment instrument. Academic Medicine. 71(10). S65–7. 3 indexed citations
14.
Moses, Arnold M., et al.. (1994). Acute Interstitial Nephritis With Renal Failure Associated With Propylthiouracil Therapy. American Journal of Kidney Diseases. 24(4). 575–577. 7 indexed citations
15.
Cleary, Lynn. (1993). Reviews and Notes: Doctors Talking with Patients/Patients Talking with Doctors: Improving Communication in Medical Visits. Annals of Internal Medicine. 119(10). 1056–1056. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026